1. BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study
   Marco Petrillo et al, 2017, American Journal of Obstetrics and Gynecology CrossRef
2. Preliminary results of targeted sequencing of BRCA1 and BRCA2 in a cohort of breast cancer families: New insight into pathogenic variants in patients and at‑risk relatives
   Marwa Saied et al, 2021, Molecular Medicine Reports CrossRef
3. K3326X and Other C-Terminal BRCA2 Variants Implicated in Hereditary Cancer Syndromes: A Review
   Scott Baughan et al, 2021, Cancers CrossRef
4. Amplification of overlapping DNA amplicons in a single-tube multiplex PCR for targeted next-generation sequencing of BRCA1 and BRCA2
   Desiree Schenk et al, 2017, PLOS ONE CrossRef
5. Clinical impact on ovarian cancer patients of massive parallel sequencing forBRCAmutation detection: the experience at Gemelli hospital and a literature review
   Angelo Minucci et al, 2015, Expert Review of Molecular Diagnostics CrossRef
6. The stem cell renewal and DNA damage response pathways are frequently altered in fibroepithelial tumors of breast in Indian patients
   Nupur Mukherjee et al, 2016, Pathology - Research and Practice CrossRef
7. BRCA Mutation Status to Personalize Management of Recurrent Ovarian Cancer: A Multicenter Study
   Claudia Marchetti et al, 2018, Annals of Surgical Oncology CrossRef
8. Cracking the Code of Human Diseases Using Next-Generation Sequencing: Applications, Challenges, and Perspectives
   Vincenza Precone et al, 2015, BioMed Research International CrossRef